Cargando…

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats

We investigated the systemic effect of sclerostin monoclonal antibody (Scl-Ab) treatment on intact non-operated bones in an open osteotomy male Sprague Dawley (SD) rat model. Six-month-old male SD rats were subjected to transverse osteotomy at the right femur mid-shaft. Rats were injected subcutaneo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suen, Pui Kit, Zhu, Tracy Y., Chow, Dick Ho Kiu, Huang, Le, Zheng, Li-Zhen, Qin, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616053/ https://www.ncbi.nlm.nih.gov/pubmed/26494536 http://dx.doi.org/10.1038/srep15632

Ejemplares similares

Sclerostin Antibody Treatment Stimulates Bone Formation to Normalize Bone Mass in Male Down Syndrome Mice
por: Williams, Diarra K, et al.
Publicado: (2017)

Effects of anti-sclerostin antibody and running on bone remodeling and strength
por: Toumi, H., et al.
Publicado: (2015)

Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis
por: Ueland, Thor, et al.
Publicado: (2019)

Effects of sclerostin antibody on bone healing
por: Mihara, Atsushi, et al.
Publicado: (2021)

Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration
por: Patalong-Wójcik, Martyna, et al.
Publicado: (2023)

Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis
por: Peng, Jia, et al.
Publicado: (2021)

The Role of Sclerostin in Bone Diseases
por: Vasiliadis, Elias S., et al.
Publicado: (2022)

Bone marrow adipoq(+) cell population controls bone mass via sclerostin in mice
por: Gao, Huanqing, et al.
Publicado: (2023)

Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
por: Fabre, Stéphanie, et al.
Publicado: (2020)

The Role of Sclerostin in Bone and Ectopic Calcification
por: De Maré, Annelies, et al.
Publicado: (2020)

Disparate bone anabolic cues activate bone formation by regulating the rapid lysosomal degradation of sclerostin protein
por: Gould, Nicole R, et al.
Publicado: (2021)

Serum Sclerostin and Its Association with Bone Turnover Marker in Metabolic Bone Diseases
por: Chen, Lihui, et al.
Publicado: (2022)

Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects
por: Yao, Yao, et al.
Publicado: (2020)

Gender-Related Impact of Sclerostin Antibody on Bone in the Osteogenesis Imperfecta Mouse
por: Cardinal, Mickaël, et al.
Publicado: (2021)

Sclerostin expression in trabecular bone is downregulated by osteoclasts
por: Koide, Masanori, et al.
Publicado: (2020)

Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones
por: Wang, Jialiang S., et al.
Publicado: (2021)

Obesity and Bone Loss at Menopause: The Role of Sclerostin
por: Marzullo, Paolo, et al.
Publicado: (2021)

Importance of Sclerostin as Bone-Muscle Mediator Crosstalk
por: Aryana, I Gusti Putu Suka, et al.
Publicado: (2022)

Sclerostin: clinical insights in muscle–bone crosstalk
por: Moretti, Antimo, et al.
Publicado: (2023)

Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass
por: Guan, Min, et al.
Publicado: (2012)

Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody
por: Boyce, Rogely Waite, et al.
Publicado: (2018)

A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair
por: Florio, Monica, et al.
Publicado: (2016)

Recombinant sclerostin inhibits bone formation in vitro and in a mouse model of sclerosteosis
por: Dreyer, Timothy, et al.
Publicado: (2021)

Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass
por: Gombos, Gabriella Császárné, et al.
Publicado: (2016)

Relation of Age, Gender, and Bone Mass to Circulating Sclerostin Levels in Women and Men
por: Mödder, Ulrike I, et al.
Publicado: (2011)

Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
por: Stegen, Steve, et al.
Publicado: (2018)

Sclerostin as a novel marker of bone turnover in athletes
por: Zagrodna, A, et al.
Publicado: (2016)

Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement
por: Shu, Rui, et al.
Publicado: (2017)

Sclerostin expression in the subchondral bone of patients with knee osteoarthritis
por: Wu, Long, et al.
Publicado: (2016)

Sclerostin's role in bone's adaptive response to mechanical loading
por: Galea, Gabriel L, et al.
Publicado: (2017)

Sclerostin Depletion Induces Inflammation in the Bone Marrow of Mice
por: Donham, Cristine, et al.
Publicado: (2021)

The roles of sclerostin and irisin on bone and muscle of orchiectomized rats
por: Zhou, Bing-na, et al.
Publicado: (2022)

Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
por: Huybrechts, Yentl, et al.
Publicado: (2023)

FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023)

Peroxisome proliferator activated receptor-γ in osteoblasts controls bone formation and fat mass by regulating sclerostin expression
por: Kim, Soohyun P., et al.
Publicado: (2023)

NOTUM inhibition increases endocortical bone formation and bone strength
por: Brommage, Robert, et al.
Publicado: (2019)

Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
por: van Bezooijen, Rutger L., et al.
Publicado: (2004)

Anti-sclerostin antibody and mechanical loading appear to influence metaphyseal bone independently in rats
por: Agholme, Fredrik, et al.
Publicado: (2011)

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy
por: Toscani, Denise, et al.
Publicado: (2018)

Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growth
por: Mathis, Noah J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_j3qpr3o5eptdo8t9uj2ej3l8vq